Goodman Noah has filed 11 insider transactions across 1 company since April 2025.
Most recent transaction: a sale of 1347 shares of Kymera Therapeutics, Inc. ($KYMR) on April 14, 2026.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 14, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | S | Common Stock | 1347 | $90.00 | 50,195.4380 | 87,300,286 | 2.61% | 0.00% |
| April 9, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | S | Common Stock | 3094 | $86.62 | 58,712.4380 | 87,300,286 | 5.01% | 0.00% |
| April 9, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | S | Common Stock | 2670 | $87.11 | 56,042.4380 | 87,300,286 | 4.55% | 0.00% |
| April 9, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | S | Common Stock | 2500 | $89.00 | 53,542.4380 | 87,300,286 | 4.46% | 0.00% |
| April 10, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | S | Common Stock | 2000 | $87.35 | 51,542.4380 | 87,300,286 | 3.74% | 0.00% |
| April 9, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | M | Stock Option (Right to Buy) | 2500 | $0.00 | 97,500.0000 | 87,300,286 | 2.50% | 0.00% |
| April 9, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | M | Common Stock | 2500 | $21.05 | 61,806.4380 | 87,300,286 | 4.22% | 0.00% |
| March 2, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Common Stock | 9225 | $0.00 | 59,306.4380 | 87,300,286 | 18.42% | 0.01% |
| March 2, 2026 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Stock Option (Right to Buy) | 18450 | $0.00 | 18,450.0000 | 87,300,286 | 9999.99% | 0.02% |
| April 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 75,043,991 | 9999.99% | 0.13% |
| April 8, 2025 | Kymera Therapeutics, Inc. | $KYMR | Goodman Noah | Chief Business Officer | A | Common Stock | 50000 | $0.00 | 50,081.4380 | 75,043,991 | 9999.99% | 0.07% |